6SZ-31286-11224
4 vaccinations
3 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-01
Dose 1 — Moderna
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 2 — Moderna
- 2021-02-25
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Migraine with aura — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Migraine symptoms including light & sound sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-05-27
- 2021-08-26
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2022-02-25
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-01
-
2022-06-12
Dose 4 — Pfizer-BioNTech
- 2022-06-24
- 2022-06-26
- 2022-07-03
- 2022-07-10
- 2022-07-17
- 2022-07-24
- 2022-09-11
- 2022-12-13
-
2023-06-12
Survey response — 12 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
- 2023-06-12
- 2023-06-13
- 2023-06-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Moderna | |
| 2 | 2021-02-25 | Moderna | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
| 4 | 2022-06-12 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-25 | Unsuccessful | |
| 2023-06-12 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Migraine symptoms including light & sound sensitivity
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Migraine with aura | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release